Cabeza Claudia, Corsi Oscar, Pérez-Cruz Pedro
Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Proyecto Epistemonikos, Santiago, Chile.
Departamento de Medicina Interna, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Proyecto Epistemonikos, Santiago, Chile.
Medwave. 2017 Dec 29;17(9):e7130. doi: 10.5867/medwave.2017.09.7130.
Cachexia and anorexia are among the most frequent symptoms in patients with cancer. Cannabinoids have been used in patients with advanced cancer; however, their role is still controversial.
To answer this question we used Epistemonikos, the largest database of systematic reviews in health, which is maintained by screening multiple information sources, including MEDLINE, EMBASE, Cochrane, among others. We extracted data from the systematic reviews, reanalyzed data of primary studies, and generated a summary of findings table using the GRADE approach.
We identified ten systematic reviews including three studies overall, of which two were randomized trials. We concluded it is not clear whether cannabinoids have any positive effect on increasing weight because the certainty of the evidence is very low. They might not have any effect on appetite, and are probably associated to frequent adverse effects.
恶病质和厌食是癌症患者最常见的症状之一。大麻素已用于晚期癌症患者;然而,其作用仍存在争议。
为回答这个问题,我们使用了Epistemonikos,这是最大的健康系统评价数据库,通过筛选包括MEDLINE、EMBASE、Cochrane等在内的多个信息来源来维护。我们从系统评价中提取数据,重新分析原始研究的数据,并使用GRADE方法生成结果总结表。
我们确定了十项系统评价,总共包括三项研究,其中两项为随机试验。我们得出结论,尚不清楚大麻素对体重增加是否有任何积极作用,因为证据的确定性非常低。它们可能对食欲没有任何影响,并且可能与频繁的不良反应有关。